Diploma (LON:DPLM) Releases Quarterly Earnings Results

Diploma logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Diploma reported strong FY2026 results: Organic revenue grew 15%, operating profit rose 42% to £487 million and EPS increased 45%; operating margin expanded to 26.5%.
  • Management expects continued growth in FY2027, guiding for 6% organic growth and 12% total revenue growth. It forecasts a lower 25.5% operating margin, reflecting planned investment, acquisition impacts and lower margins at Peerless.
  • Diploma completed 16 acquisitions since the start of FY2026, investing £368 million and adding about £50 million in annualized operating profit; meanwhile, Life Sciences organic growth was just 1% amid challenging markets.
  • MarketBeat previews the top five stocks to own by December 1st.

Diploma (LON:DPLM - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX 255.60 earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 184.03 billion during the quarter. Diploma had a return on equity of 18.55% and a net margin of 9.42%.

Here are the key takeaways from Diploma's conference call:

  • Diploma reported a strong FY2026: organic revenue grew 15%, operating profit rose 42% to £487 million, and EPS increased 45%. Operating margin expanded 400 basis points to 26.5%, with return on capital at 25.3%.
  • Management expects another strong year in FY2027, guiding to 6% organic growth and 12% total revenue growth, with further EPS growth. It expects double-digit organic growth in Q1, followed by slower growth in Q2 and Q3 against tougher comparisons.
  • The company completed 16 acquisitions since the start of FY2026, investing £368 million and adding about £50 million of annualized operating profit; further deals completed after year-end are expected to contribute to FY2027. Management said its pipeline remains strong, while emphasizing returns discipline and available balance-sheet capacity.
  • FY2027 operating margin is forecast at 25.5%, down from 26.5%, reflecting planned investment, lower margins at Peerless and dilution from acquisitions. Management also expects cash conversion to settle around 90% as it invests in inventory to support growth.
  • Life Sciences had just 1% organic growth as healthcare markets remained challenging and more products than usual reached the end of their life cycles. Management expects near-term growth to remain modest, while pointing to a healthy longer-term product pipeline.

Diploma Stock Performance

Shares of DPLM traded down GBX 130 during trading hours on Wednesday, hitting GBX 6,855. The stock had a trading volume of 815,122 shares, compared to its average volume of 2,510,888. The firm has a market capitalization of £9.19 billion, a PE ratio of 48.69, a PEG ratio of 2.82 and a beta of 0.92. The company has a debt-to-equity ratio of 47.65, a current ratio of 2.06 and a quick ratio of 0.80. The stock has a fifty day moving average price of GBX 7,427.48 and a 200 day moving average price of GBX 6,819.16. Diploma has a 12 month low of GBX 4,970 and a 12 month high of GBX 7,980.

Analyst Ratings Changes

Several brokerages recently commented on DPLM. JPMorgan Chase & Co. increased their price objective on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the company an "overweight" rating in a research report on Monday, August 24th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 9,000 target price on shares of Diploma in a report on Wednesday. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a GBX 7,400 target price on shares of Diploma in a report on Tuesday, September 8th. Six analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of GBX 7,400.

Check Out Our Latest Report on DPLM

Latest Diploma News

These are some of the DPLM news items that stood out recently:

Insider Activity

In other Diploma news, insider Katie Bickerstaffe  bought 246 shares of the business's stock in a transaction that occurred on Wednesday, September 23rd. The stock was bought at an average cost of GBX 7,696 per share, for a total transaction of £18,932.16. 1.14% of the stock is currently owned by corporate insiders.

About Diploma

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Read More

Earnings History for Diploma (LON:DPLM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Diploma Right Now?

Before you consider Diploma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.

While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines